Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 May 1;184(5):519-527.
doi: 10.1001/jamainternmed.2024.0001.

Text vs Patient Portal Messaging to Improve Influenza Vaccination Coverage: A Health System-Wide Randomized Clinical Trial

Affiliations
Randomized Controlled Trial

Text vs Patient Portal Messaging to Improve Influenza Vaccination Coverage: A Health System-Wide Randomized Clinical Trial

Peter G Szilagyi et al. JAMA Intern Med. .

Abstract

Importance: Increasing influenza vaccination rates is a public health priority. One method recommended by the US Centers for Disease Control and Prevention and others is for health systems to send reminders nudging patients to be vaccinated.

Objective: To evaluate and compare the effect of electronic health record (EHR)-based patient portal reminders vs text message reminders on influenza vaccination rates across a health system.

Design, setting, and participants: This 3-arm randomized clinical trial was conducted from September 7, 2022, to April 30, 2023, among primary care patients within the University of California, Los Angeles (UCLA) health system.

Interventions: Arm 1 received standard of care. The health system sent monthly reminder messages to patients due for an influenza vaccine by portal (arm 2) or text (arm 3). Arm 2 had a 2 × 2 nested design, with fixed vs responsive monthly reminders and preappointment vs no preappointment reminders. Arm 3 had 1 × 2 design, with preappointment vs no preappointment reminders. Preappointment reminders for eligible patients were sent 24 and 48 hours before scheduled primary care visits. Fixed reminders (in October, November, and December) involved identical messages via portal or text. Responsive portal reminders involved a September message asking patients about their plans for vaccination, with a follow-up reminder if the response was affirmative but the patient was not yet vaccinated.

Main outcomes and measures: The primary outcome was influenza vaccination by April 30, 2023, obtained from the UCLA EHR, including vaccination from pharmacies and other sources.

Results: A total of 262 085 patients (mean [SD] age, 45.1 [20.7] years; 237 404 [90.6%] adults; 24 681 [9.4%] children; 149 349 [57.0%] women) in 79 primary care practices were included (87 257 in arm 1, 87 478 in arm 2, and 87 350 in arm 3). At the entire primary care population level, none of the interventions improved influenza vaccination rates. All groups had rates of approximately 47%. There was no statistical or clinically significant improvement following portal vs text, preappointment reminders vs no preappointment reminders (portal and text reminders combined), or responsive vs fixed monthly portal reminders.

Conclusions and relevance: At the population level, neither portal nor text reminders for influenza vaccination were effective. Given that vaccine hesitancy may be a major reason for the lack of impact of portal or text reminders, more intensive interventions by health systems are needed to raise influenza vaccination coverage levels.

Trial registration: ClinicalTrials.gov Identifier: NCT05525494.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Szilagyi reported receiving grants from the National Institutes of Health (NIH) and NIH/National Center for Advancing Translational Sciences (NCATS) during the conduct of the study. Dr Duru reported consulting for ExactCare Pharmacy. Dr Humiston reported receiving personal fees from Sanofi and grants from GSK and Pediatric Infectious Disease Society outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Study Flow Diagram

Similar articles

Cited by

References

    1. Grohskopf LA, Alyanak E, Broder KR, et al. . Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices—United States, 2020-21 influenza season. MMWR Recomm Rep. 2020;69(8):1-24. doi:10.15585/mmwr.rr6908a1 - DOI - PMC - PubMed
    1. US Centers for Disease Control and Prevention . 2022-2023 US flu season: preliminary in-season burden estimates. Accessed June 14, 2023. https://www.cdc.gov/flu/about/burden/preliminary-in-season-estimates.htm
    1. Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices–United States, 2018-19 influenza season. MMWR Recomm Rep. 2018;67(3):1-20. doi:10.15585/mmwr.rr6703a1 - DOI - PMC - PubMed
    1. US Centers for Disease Control and Prevention . Flu vaccination coverage, United States, 2021–22 influenza season. Accessed June 14, 2023. https://www.cdc.gov/flu/fluvaxview/coverage-2022estimates.htm
    1. US Centers for Disease Control and Prevention . Weekly flu vaccination dashboard. Accessed June 14, 2023. https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-dashboard.html

Publication types

Substances

Associated data